Novartis will take intensive steps to develop an experimental drug against Covid-19, following encouraging results that show significantly lower rates of adverse health outcomes of patients receiving the antiviral drug in mid-range clinical trials. Covid patients receiving ensovibep treatment showed a 78% reduced risk of needing to be taken to an Intensive Care Unit, hospitalized […]
Tag: coronavirus drug
COVID-19: AstraZeneca antibody drug offers 83% protection over six months
AstraZeneca announced today that its anti-COVID-19 antibody drug was 83% effective in reducing the risk of developing a symptomatic disease over a six-month period, according to a follow-up test. This treatment, given in injectable form and called AZD7442 or Evusheld, had previously been shown to provide 77% protection against symptomatic disease after three months, in […]